Potential use of data-mining algorithms for the detection of 'surprise' adverse drug reactions

Drug Safety

Volumn 30, Issue 2, 2007, Pages 143-155

  Hauben, Manfred ^a,b,c   Horn, Sebastian ^d   Reich, Lester ^a  

^a PFIZER INC   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NEW YORK MEDICAL COLLEGE   (United States)

^d BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; ALPHA INTERFERON; ALPHA2B INTERFERON; BUMETANIDE; CAPTOPRIL; CARBAMAZEPINE; CEFTRIAXONE; CIPROFLOXACIN; CLOZAPINE; COTRIMOXAZOLE; DEXAMETHASONE; DOBUTAMINE; ERYTHROMYCIN; HYDROCHLOROTHIAZIDE; IBUPROFEN; ISOTRETINOIN; ITRACONAZOLE; MEFLOQUINE; METHYLPREDNISOLONE; MONTELUKAST; OMEPRAZOLE; PAMIDRONIC ACID; PEGINTERFERON; PEGINTERFERON ALPHA; PROPOFOL; TOPIRAMATE; UNCLASSIFIED DRUG; UNINDEXED DRUG; WARFARIN; ZOLEDRONIC ACID; ZONISAMIDE;

AKATHISIA; ALGORITHM; ANAPHYLAXIS; ANHIDROSIS; ARTICLE; ASEPTIC MENINGITIS; BONE NECROSIS; CHOLELITHIASIS; CHURG STRAUSS SYNDROME; COUGHING; DATA ANALYSIS; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; DYSPHONIA; DYSTONIA; EOSINOPHILIA; EYE INFLAMMATION; FEVER; HEART FAILURE; HICCUP; HOARSENESS; HUMAN; HYPERCHOLESTEROLEMIA; HYPERKALEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; IMMUNE DEFICIENCY; LUNG EDEMA; LYMPHOCYTIC COLITIS; MUSCULOSKELETAL DISEASE; MYALGIA; MYOPIA; PARKINSONISM; PNEUMONIA; POSTMARKETING SURVEILLANCE; PRIAPISM; PRIORITY JOURNAL; PYLORUS STENOSIS; SKIN NECROSIS; TENDINITIS; TREMOR; UVEITIS; XEROSTOMIA;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ALGORITHMS; BAYES THEOREM; DATA INTERPRETATION, STATISTICAL; DRUG THERAPY; HUMANS; MODELS, STATISTICAL; POISSON DISTRIBUTION; RESEARCH DESIGN; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 33846665203     PISSN: 01145916     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002018-200730020-00004     Document Type: Article

References (21)

1. Finney DJ. The detection of adverse reactions to therapeutic drugs. Stat Med 1982; 1 (2): 153-61
2. Trontell A. Expecting the unexpected: drug safety, pharmacovigilance and the prepared mind. N Engl J Med 2004; 351 (14): 1385-7
3. Hauben M, Madigan D, Gerrits CM, et al. The role of data mining in pharmacovigilance. Expert Opin Drug Saf 2005; 4 (5): 929-48
4. Aronson JK, Ferner RE. Clarification of terminology in drug safety. Drug Saf 2005; 28 (10): 851-70
5. Hauben M, Reich L. Potential utility of data-mining algorithms for early detection of potentially fatal / disabling adverse drug reactions: a retrospective evaluation. J Clin Pharmacol 2005; 45: 378-84
6. Szarfman A, Machado SG, O'Neill RT. Use of screening algorithms and computer systems to efficiently signal higher-than-expected combinations of drugs and reactions in the US FDA's spontaneous reports database. Drug Saf 2002; 25 (6): 381-92
7. Hauben M, Reich L. Reports of acute angle closure glaucoma-related adverse events with SSRIs: results of a disproportional ity analysis. CNS Drugs 2006; 20 (4): 327-9
8. Facts and comparisons 4.0 [online]. Available from URL: http://online.factsandcomparisons.com/ [Accessed 2006 Sep 25]
9. Lehman H, Chen J, Gould LA. An evaluation of computer-aided disproportionality analysis for post-marketing signal detection. Pharmacoepidemiol Drug Saf 2006 Aug; 15 Suppl. 1: S106-7
10. U.S. Food and Drug Administration. 2003 Safety Alert: topamax (topiramate) tablets/sprinkle capsules [online]. Available from URL: http://www.fda.gov/medwatch/SAFETY/2003/topamax.htm [Accessed 2006 Sep 25]
11. Hauben M, Reich L, Chung S. Postmarketing surveillance of potentially fatal reactions to oncology drugs: potential utility of two signal-detection algorithms. Eur J Clin Pharmacol 2004; 60 (10): 747-50
12. Hand DJ, Blunt G, Kelly MG, et al. Data mining for fun and profit. Stat Sci 2000; 15 (2): 111-31
13. Banks D, Woo EJ, Burwen DR, et al. Comparing data mining methods on the VAERS database. Pharmacoepidemiol Drug Saf 2005; 14 (9): 601-9
14. Hauben M, Reich L. Response to letter by Levine, et al. Br J Clin Pharmacol 2006; 61 (1): 115-7
15. Hauben M. Trimethoprim-induced hyperkalaemia: lessons in data mining. Br J Clin Pharmacol 2004; 58 (3): 338-9
16. Hauben M, Reich L. A case report of rhabdomyolysis with pentamidine that prompted a retrospective evaluation of a pharmacovigilance tool under investigation. Br J Clin Pharmacol 2004; 58 (6): 675-6
17. Hauben M, Reich L. Drug-induced pancreatitis: lessons in data mining. Br J Clin Pharmacol 2004; 58 (5): 560-2
18. Fawcett T. An introduction to ROC analysis. Pattern Recognition Lett 2006; 27 (8): 861-74
19. Bate A, Edwards IR. Data mining in spontaneous reports. Basic Clin Pharmacol Toxicol 2006; 98 (3): 324-30
20. Hauben M, Reich L, van Puijenbroek EP, et al. Data mining in pharmacovigilance: lessons from phantom ships. Eur J Clin Pharmacol 2006; 62 (11): 967-70
21. Hauben M, Patadia VK, Goldsmith D. What counts in data mining. Drug Saf 2006; 29 (10): 827-32